Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method
Nick Verougstraete, Veronique Stove, Alain Verstraete, Alain G. Verstraete, Christophe P. Stove
Topics & Concepts
BosutinibChemistryPonatinibIbrutinibDasatinibNilotinibChromatographyWhole bloodProtein precipitationTherapeutic drug monitoringImatinib mesylateMyeloid leukemiaChronic lymphocytic leukemiaPharmacologyTyrosine kinaseImatinibLeukemiaPharmacokineticsMass spectrometryCancer researchInternal medicineMedicineBiochemistrySignal transductionChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia research